115933-30-7Relevant articles and documents
Synthesis of carbohydrazides and carboxamides as anti-tubercular agents
Kumar, Gautam,Krishna, Vagolu Siva,Sriram, Dharmarajan,Jachak, Sanjay M.
, p. 871 - 884 (2018)
A novel series of furan/thiophene carbohydrazides and carboxamides were synthesized and evaluated for anti-TB and cytotoxic activities. All the synthesized compounds were characterized using 1H and 13C NMR and mass spectral technique
Broadening antifungal spectrum and improving metabolic stablity based on a scaffold strategy: Design, synthesis, and evaluation of novel 4-phenyl-4,5-dihydrooxazole derivatives as potent fungistatic and fungicidal reagents
Cheng, Maosheng,Cui, Hengxian,Jiang, Hong,Liu, Lei,Su, Xin,Sun, Yin,Wu, Tianxiao,Yin, Wenbo,Zhang, Yuxin,Zhao, Dongmei,Zhao, Liyu
, (2021/11/11)
5-phenylthiophene derivatives exhibited excellent antifungal activity against Candida albicans, Candida tropicalis and Cryptococcus neoformans. However, optimal compound 7 was inactive against Aspergillus fumigatus and unstable in human liver microsomes in vitro with a half-life of 18.6 min. To discover antifungal agents with a broad spectrum and improve the metabolic properties of the compounds, the scaffold hopping strategy was adopted and a series of 4-phenyl-4,5-dihydrooxazole derivatives were designed and synthesized. It was especially encouraging that compound 22a displayed significant antifungal activities against eight susceptible strains and seven FLC-resistant strains. Furthermore, the potent compound 22a could prevent the formation of fungalbiofilms and displayed satisfactory fungicidal activity. In addition, the metabolic stability of compound 22a was improved significantly, with the half-life of 70.5 min. Compound 22a was almost nontoxic to mammalian A549, MCF-7, HepG2, and 293T cells. Moreover, pharmacokinetic studies in SD rats showed that compound 22a exhibited pharmacokinetic properties with a bioavailability of 15.22% and a half-life of 4.44 h, indicating that compound 22a is worthy of further study.
Synthetic method of 2-(4-fluorophenyl) thiophene
-
, (2017/02/24)
The invention discloses a synthetic method of 2-(4-fluorophenyl) thiophene. The synthetic method comprises the following steps: 1), performing Vilsmeier-Haack reaction on 4-fluoroacetophenone under the action of solid triphosgene and N,N-dimethylfomamide to obtain 2-chloro-2-(4-fluorophenyl) acetaldehyde; 2), performing ring-closing reaction between 2-chloro-2-(4-fluorophenyl) acetaldehyde and ethyl thioglycolate under the action of alkali to obtain 5-(4-fluorophenyl) thiophene-2-carboxylic acid ethyl ester; 3), performing esterolysis on 5-(4-fluorophenyl) thiophene-2-carboxylic acid ethyl ester under the action of alkali to obtain 5-(4-fluorophenyl) thiophene-2-formic acid; and 4), preparing 2-(4-fluorophenyl) thiophene from 5-(4-fluorophenyl) thiophene-2-formic acid under the catalysis of copper powder. The invention provides a synthetic method with low-price and easily-available raw materials and mild reaction conditions for synthesis of 2-(4-fluorophenyl) thiophene, the entire reaction has no special requirements on equipment and reaction conditions, and the yield of a product is relatively high; and the synthetic method is simple and convenient to operate, can ensure the safety of operators, and has a good market prospect.
Synthesis of 2-arylmethyl-5-aryl-thiophene
-
, (2015/11/09)
The present invention provides a new synthetic process for the production of 2-arylmethyl-5-aryl-thiophene, an intermediate in the synthesis of C-aryl glycosides.
NOVEL NEUROTRYPSIN INHIBITORS
-
Page/Page column 28, (2012/05/20)
The invention relates to novel acylamino-hydroxy-benzamides of formula (I), wherein R1 is phenyl substituted by phenyl, phenoxy, phenylamino or heteroaryl, all optionally further substituted; bicyclic aryl, monocyclic heteroaryl substituted by
Amide compounds
-
Page column 13, (2010/02/07)
The present invention is a compound and pharmaceutical composition comprising a compound of formula (I): wherein R1is a 4-(lower) alkyl-imidazol-1-yl or a 4,5-di(lower) alkyl-imidazol-1-yl group, R2is a hydrogen atom or a lower alkyl